메뉴 건너뛰기




Volumn 42, Issue 10, 2010, Pages 3998-4002

Desensitization protocol in highly hla-sensitized and ABO-incompatible high titer kidney transplantation

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; HLA ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RITUXIMAB; TACROLIMUS;

EID: 78650447011     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.043     Document Type: Conference Paper
Times cited : (30)

References (13)
  • 1
    • 3042741071 scopus 로고    scopus 로고
    • Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan
    • K. Takahashi, K. Saito, and S. Takahara Excellent long-term outcome of ABO-incompatible living donor kidney transplantation in Japan Am J Transplant 4 2004 1089
    • (2004) Am J Transplant , vol.4 , pp. 1089
    • Takahashi, K.1    Saito, K.2    Takahara, S.3
  • 2
    • 47949092851 scopus 로고    scopus 로고
    • A case of early graft loss due to hyperacute rejection after ABO-incompatible renal transplantation
    • K. Horie, Y. Kanou, and M. Sato A case of early graft loss due to hyperacute rejection after ABO-incompatible renal transplantation Clin Transplant 22 2008 42
    • (2008) Clin Transplant , vol.22 , pp. 42
    • Horie, K.1    Kanou, Y.2    Sato, M.3
  • 3
    • 59849100611 scopus 로고    scopus 로고
    • Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients
    • S.C. Jordan, A. Peng, and A.A. Vo Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients Contrib Nephrol 162 2009 13
    • (2009) Contrib Nephrol , vol.162 , pp. 13
    • Jordan, S.C.1    Peng, A.2    Vo, A.A.3
  • 4
    • 51249119202 scopus 로고    scopus 로고
    • A novel approach to successful ABO-incompatible high-titer renal transplantation
    • J. Uchida, T. Iwai, and M. Kato A novel approach to successful ABO-incompatible high-titer renal transplantation Transplant Proc 40 2008 2285
    • (2008) Transplant Proc , vol.40 , pp. 2285
    • Uchida, J.1    Iwai, T.2    Kato, M.3
  • 5
    • 47549105407 scopus 로고    scopus 로고
    • Rituximab and intravenous immune globulin for desensitization during renal transplantation
    • A.A. Vo, M. Lukovsky, and M. Toyoda Rituximab and intravenous immune globulin for desensitization during renal transplantation N Engl J Med 359 2008 242
    • (2008) N Engl J Med , vol.359 , pp. 242
    • Vo, A.A.1    Lukovsky, M.2    Toyoda, M.3
  • 6
    • 10744232375 scopus 로고    scopus 로고
    • Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1: Safety, pharmacodynamics, and pharmacokinetics
    • C.A. Vieira, A. Agarwal, and B.K. Book Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1 Safety, pharmacodynamics, and pharmacokinetics Transplantation 77 2004 542
    • (2004) Transplantation , vol.77 , pp. 542
    • Vieira, C.A.1    Agarwal, A.2    Book, B.K.3
  • 7
    • 33751193502 scopus 로고    scopus 로고
    • ABO-incompatible renal transplantation without splenectomy between husband and wife among the ever oldest patients
    • N. Mitsuhata, S. Ito, and R. Fujita ABO-incompatible renal transplantation without splenectomy between husband and wife among the ever oldest patients Am J Transplant 6 2006 3040
    • (2006) Am J Transplant , vol.6 , pp. 3040
    • Mitsuhata, N.1    Ito, S.2    Fujita, R.3
  • 8
    • 61849155125 scopus 로고    scopus 로고
    • Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients
    • D. Toki, H. Ishida, and S. Horita Impact of low-dose rituximab on splenic B cells in ABO-incompatible renal transplant recipients Transpl Int 22 2009 447
    • (2009) Transpl Int , vol.22 , pp. 447
    • Toki, D.1    Ishida, H.2    Horita, S.3
  • 9
    • 28544436013 scopus 로고    scopus 로고
    • Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation
    • N. Mitsuhata, R. Fujita, and S. Ito Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation Transplantation 80 2005 1355
    • (2005) Transplantation , vol.80 , pp. 1355
    • Mitsuhata, N.1    Fujita, R.2    Ito, S.3
  • 10
    • 2442665405 scopus 로고    scopus 로고
    • Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma
    • B. Lemieux, S. Tartas, and C. Traulle Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma Bone Marrow Transplant 33 2004 921
    • (2004) Bone Marrow Transplant , vol.33 , pp. 921
    • Lemieux, B.1    Tartas, S.2    Traulle, C.3
  • 11
    • 33947591440 scopus 로고    scopus 로고
    • The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection
    • J.E. Locke, A.A. Zachary, and M. Haas The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection Am J Transplant 7 2007 842
    • (2007) Am J Transplant , vol.7 , pp. 842
    • Locke, J.E.1    Zachary, A.A.2    Haas, M.3
  • 12
    • 0031812627 scopus 로고    scopus 로고
    • Suppression of panel-reactive antibodies by treatment with mycophenolate mofetil
    • C. Schmid, H.S. Garritsen, and R. Kelsch Suppression of panel-reactive antibodies by treatment with mycophenolate mofetil Thorac Cardiovasc Surg 46 1998 161
    • (1998) Thorac Cardiovasc Surg , vol.46 , pp. 161
    • Schmid, C.1    Garritsen, H.S.2    Kelsch, R.3
  • 13
    • 21244502171 scopus 로고    scopus 로고
    • Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil
    • M. Mannami, and N. Mitsuhata Improved outcomes after ABO-incompatible living-donor kidney transplantation after 4 weeks of treatment with mycophenolate mofetil Transplantation 79 2005 1756
    • (2005) Transplantation , vol.79 , pp. 1756
    • Mannami, M.1    Mitsuhata, N.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.